A call for a fresh new look at the plasma proteome

Proteomics - Clinical Applications

Volumn 6, Issue 9-10, 2012, Pages 443-446

  Hanash, Samir ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Biomarkers; Plasma; Proteomics

Indexed keywords

GLYCOPEPTIDE; PROTEOME; TRYPSIN;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INSTRUMENTATION; LIQUID CHROMATOGRAPHY; MEDICAL SOCIETY; METHODOLOGY; NANOSENSOR; NANOTECHNOLOGY; OPEN READING FRAME; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DATABASE; PROTEOMICS; TANDEM MASS SPECTROMETRY;

BIOLOGICAL MARKERS; HUMANS; MASS SPECTROMETRY; PROTEOME; PROTEOMICS;

EID: 84868119565     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201200052     Document Type: Article

References (33)

1. Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W. et al., Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly available database. Proteomics 2005, 5, 3226-3245.
2. States, D. J., Omenn, G. S., Blackwell, T. W., Fermin, D. et al., Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol. 2006, 24, 333-338.
3. Tan, H. T., Lee, Y. H., Chung, M. C., Cancer proteomics. Mass Spectrom. Rev. 2012, 31, 583-605.
4. Hoskins, E. R., Hood, B. L., Sun, M., Krivak, T. C. et al., Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation. PLOS One 2011, 6, e25056.
5. Jin, H., Lee, H. C., Park, S. S., Jeong, Y. S. et al., Serum cancer biomarker discovery through analysis of gene expression data sets across multiple tumor and normal tissues. J. Biomed. Inform. 2011, 44, 1076-1085.
6. Ray, S., Reddy, P. J., Jain, R., Gollapalli, K. et al., Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead. Proteomics 2011, 11, 2139-2161.
7. Teng, P. N., Hood, B. L., Sun, M., Dhir, R. et al., Differential proteomic analysis of renal cell carcinoma tissue interstitial fluid. J. Proteome Res. 2011, 10, 1333-1342.
8. Kim, Y. J., Zaidi-Ainouch, Z., Gallien, S., Domon, B. Mass spectrometry-based detection and quantification of plasma glycoproteins using selective reaction monitoring. Nat. Protoc. 2012, 7, 859-871.
9. Ishihara, T., Fukuda, I., Morita, A., Takinami, Y. et al., Development of quantitative plasma N-glycoproteomics using label-free 2-D LC-MALDI MS and its applicability for biomarker discovery in hepatocellular carcinoma. J. Proteomics 2011, 74, 2159-2168.
10. Zeng, Z., Hincapie, M., Pitteri, S. J., Hanash, S. et al., A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome. Anal. Chem. 2011, 83, 4845-4854.
11. Chen, G., Gharib, T. G., Huang, C. C., Taylor, J. et al., Discordant protein and mRNA expression in lung adenocarcinomas. Mol. Cell. Proteomics 2002, 1, 304-313.
12. Grolleau, A., Bowman, J., Pradet-Balade, B., Hanash, S. et al., Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics. J. Biol. Chem. 2002, 277, 22175-22184.
13. Hanash, S., Schliekelman, M., Zhang, Q., Taguchi, A., Integration of proteomics into systems biology of cancer. Wiley interdisciplinary reviews systems biology and medicine. WIREs Syst. Biol. Med. 2012, 4, 327-337.
14. Gold, L., Walker, J. J., Wilcox, S. K., Williams, S., Advances in human proteomics at high scale with the SOMAscan proteomics platform. Nat. Biotechnol. 2011, 29, 543-549.
15. Holm, A., Wu, W., Lund-Johansen, F., Antibody array analysis of labelled proteomes: how should we control specificity? Nat. Biotechnol. 2011, 29, 578-585.
16. Shi, T., Su, D., Liu, T., Tang, K. et al., Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics. Proteomics 2012, 12, 1074-1092.
17. Ivanov, Y. D., Govorun, V. M., Bykov, V. A., Archakov, A. I., Nanotechnologies in proteomics. Proteomics 2006, 6, 1399-1414.
18. Faca, V., Pitteri, S. J., Newcomb, L., Glukhova, V. et al., Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. J. Proteome Res. 2007, 6, 3558-3565.
19. Zhang, Q., Faca, V., Hanash, S., Mining the plasma proteome for disease applications across seven logs of protein abundance. J. Proteome Res. 2011, 10, 46-50.
20. Michalski, A., Damoc, E., Lange, O., Denisov, E. et al., Ultra high resolution linear ion trap Orbitrap mass spectrometer (Orbitrap Elite) facilitates top down LC-MS/MS and versatile peptide fragmentation modes. Mol. Cell Proteomics 2012, 11, O111.013698.
21. Farrah, T., Deutsch, E. W., Omenn, G. S., Campbell, D. S. et al., A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol. Cell Proteomics 2011, 10, M110 006353.
22. Pitteri, S. J., Hanash, S. M., Aragaki, A., Amon, L. M. et al., Postmenopausal estrogen and progestin effects on the serum proteome. Genome Med. 2009, 1, 121.
23. Prentice, R. L., Paczesny, S., Aragaki, A., Amon, L. M. et al., Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling. Genome Med. 2010, 2, 48.
24. Wang, H., Wong, C. H., Chin, A., Taguchi, A. et al., Integrated mass spectrometry-based analysis of plasma glycoproteins and their glycan modifications. Nat. Protoc. 2011, 6, 253-269.
25. Jones, P., Cote, R. G., Martens, L., Quinn, A. F. et al., PRIDE: a public repository of protein and peptide identifications for the proteomics community. Nucleic Acids Res. 2006, 34, D659-D63.
26. Deutsch, E. W., Eng, J. K., Zhang, H., King, N. L. et al., Human plasma PeptideAtlas. Proteomics 2005, 5, 3497-500.
27. Zhang, H., Loriaux, P., Eng, J., Campbell, D. et al., UniPep-a database for human N-linked glycosites: a resource for biomarker discovery. Genome Biol. 2006, 7, R73.
28. Craig, R., Cortens, J. P., Beavis, R. C., Open source system for analyzing, validating, and storing protein identification data. J. Proteome Res. 2004, 3, 1234-1242.
29. Mathivanan, S., Ahmed, M., Ahn, N. G., Alexandre, H. et al., Human proteinpedia enables sharing of human protein data. Nat. Biotechnol. 2008, 26, 164-167.
30. Gaster, R. S., Hall, D. A., Nielsen, C. H., Osterfeld, S. J. et al., Matrix-insensitive protein assays push the limits of biosensors in medicine. Nat. Med. 2009, 15, 1327-1332.
31. Shafer, M. W., Mangold, L., Partin, A. W., Haab, B. B., Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease. Prostate 2007, 67, 255-267.
32. Weibrecht, I., Leuchowius, K. J., Clausson, C. M., Conze, T. et al., Proximity ligation assays: a recent addition to the proteomics toolbox. Expert Rev. Proteomics 2010, 7, 401-409.
33. Vaisocherova, H., Zhang, Z., Yang, W., Cao, Z. et al., Functionalizable surface platform with reduced nonspecific protein adsorption from full blood plasma-material selection and protein immobilization optimization. Biosens. Bioelectron. 2009, 24, 1924-1930.